Skip to main content
PLOS One logoLink to PLOS One
. 2024 May 10;19(5):e0303027. doi: 10.1371/journal.pone.0303027

Potential of MALDI-TOF MS biotyping to detect deltamethrin resistance in the dengue vector Aedes aegypti

Lionel Almeras 1,2,3,*, Monique Melo Costa 1,2,3, Rémy Amalvict 1,2,3,4, Joseph Guilliet 5, Isabelle Dusfour 6, Jean-Philippe David 5, Vincent Corbel 7,8
Editor: Joseph Banoub9
PMCID: PMC11086877  PMID: 38728353

Abstract

Insecticide resistance in mosquitoes is spreading worldwide and represents a growing threat to vector control. Insecticide resistance is caused by different mechanisms including higher metabolic detoxication, target-site modification, reduced penetration and behavioral changes that are not easily detectable with simple diagnostic methods. Indeed, most molecular resistance diagnostic tools are costly and labor intensive and then difficult to use for routine monitoring of insecticide resistance. The present study aims to determine whether mosquito susceptibility status against the pyrethroid insecticides (mostly used for mosquito control) could be established by the protein signatures of legs and/or thoraxes submitted to MALDI-TOF Mass Spectrometry (MS). The quality of MS spectra for both body parts was controlled to avoid any bias due to unconformity protein profiling. The comparison of MS profiles from three inbreeds Ae. aegypti lines from French Guiana (IRF, IR03, IR13), with distinct deltamethrin resistance genotype / phenotype and the susceptible reference laboratory line BORA (French Polynesia), showed different protein signatures. On both body parts, the analysis of whole protein profiles revealed a singularity of BORA line compared to the three inbreeding lines from French Guiana origin, suggesting that the first criteria of differentiation is the geographical origin and/or the breeding history rather than the insecticide susceptibility profile. However, a deeper analysis of the protein profiles allowed to identify 10 and 11 discriminating peaks from leg and thorax spectra, respectively. Among them, a specific peak around 4870 Da was detected in legs and thoraxes of pyrethroid resistant lines compared to the susceptible counterparts hence suggesting that MS profiling may be promising to rapidly distinguish resistant and susceptible phenotypes. Further work is needed to confirm the nature of this peak as a deltamethrin resistant marker and to validate the routine use of MS profiling to track insecticide resistance in Ae. aegypti field populations.

Introduction

Aedes (Ae.) aegypti (Diptera: Culicidae) is an urban mosquito species that can transmit viruses to humans causing infectious diseases, such as dengue, yellow fever, Zika, and chikungunya. The geographic distribution of this pest is the widest ever recorded in history and it represents an increasing public health threat [1]. The absence of specific antiviral treatments and the lack of vaccines or when available the low vaccination coverage underlined that the best protection method remains to avoid human exposure to Ae. aegypti bites [2]. Larval source management, community mobilization and chemical insecticides remain the first line of defense against this pest [3,4]. Unfortunately, the continuous use of public health pesticides for more than 40 years increased aversion of citizens to strategies based solely on insecticides because of their potential impacts on the environment and global health [4]. Furthermore, the use of the same insecticides in vector control for decades has selected mosquito resistances to all public health insecticides. Resistance in Ae. aegypti and Ae. albopictus is now present in at least 57 countries in South East Asia, Africa, the Americas and the Caribbean, where the burden of arboviral diseases is the highest [5]. Evidence of reduced susceptibility to insecticides has also been recently reported in invasive Aedes mosquitoes in Europe, especially from Italy, Greece and Spain [6,7], hence confirming that resistance is spreading rapidly across continents. In this context, there is a need for more adequate, scalable and affordable tools for tracking insecticide resistant mosquitoes in the field to prevent further spread.

Different mechanisms are known to confer resistance to chemical insecticides. One of the most widespread and known mechanisms is knockdown resistance (kdr) causing resistance to dichlorodiphenyltrichloroethane (DDT) and pyrethroids [8]. The mechanism is associated with point mutations affecting the gene encoding the voltage-gated sodium channel (VGSC), which is involved in the beginning and propagation of action potentials in the nervous system [8]. The mechanism was originally discovered in the housefly and then identified in a large number of arthropods including mosquitoes [9,10]. In Ae. Aegypti, several kdr mutations are known to confer resistance to pyrethroids and DDT including the V410L(a substitution of a valine to leucine at position 410), S989P, V1016I/G (i.e. a substitution of a valine to either isoleucine or glycine at position 1016) and F1534C (i.e. a substitution of a phenylalanine to cysteine at position 1534) mutations that were found in different regions of the world [11]. In addition, metabolic resistance through the over-expression of detoxifying enzymes belonging to Monooxygenases (P450s), Glutathione-S-Transferases (GSTs) and Carboxylesterases (CCEAs) can also confer high level of resistance to various classes of insecticides including pyrethroids [12,13]. Recent studies showed that additional mechanisms such as reduced insecticide penetration due to change in the thickness and/or composition of the cuticle [14,15] confer the insect the capacity to resist to multiple classes of insecticides.

Current methods for resistance monitoring rely on biological, biochemical and molecular assays that all have technical and/or operational constraints (e.g. lack of sensitivity or specificity, cost, low throughput). The strength and weakness of each method were previously reported by Dusfour et al [16]. Developing novel affordable and accurate strategies to detect resistant mosquitoes at high-throughput would facilitate the implementation of timely and locally adapted insecticide resistance management strategies.

Recently, an innovative method based on the analysis of protein profiles obtained by Matrix-Assisted Laser Desorption/Ionization time-of-flight mass spectrometry (MALDI-TOF MS) profiling, was applied to arthropod identification [17,18]. Since 2013, we conducted pioneering studies, applying successfully this approach to the identification of several arthropod family such as mosquitoes, ticks, fleas or culicoides [1922] as well as to the identification of blood source of engorged mosquitoes [23]. The principle of the classification is based on matching of query MS profiles with a MS reference spectra database (RSDB). The correct classification requires however that MS spectra are intra-species reproducible and inter-species specific. As for most phenotypic approaches, MS protein profiles could vary according to body part, developmental stages or sample preparation mode [24]. Then, to compare and to share MS results, a standardization of the protocols were previously established for mosquitoes [25,26]. We also showed that the independent submission of legs and thorax from the same specimen to MALDI-TOF MS [27] can improve the identification rate and confidence level, that may be decisive for discriminating similar phenotypes, such as cryptic species [26,28].

In this context, the aim of the present work was to determine whether resistance to the pyrethroid ester insecticide, could be detected in Ae. aegypti by analyzing the protein signatures of legs and/or thoraxes resulting from MALDI-TOF MS. In this way, MS profiles from four Ae. aegypti colonies, including one susceptible reference laboratory line from French Polynesia and three inbreeding lines from French Guiana showing distinct resistance phenotypes to deltamethrin were compared.

Material and methods

Mosquito laboratory breeding

Four Ae. aegypti colonies, including the susceptible reference laboratory line Bora-Bora (BORA) and three isofemale lines from French Guiana with distinct deltamethrin resistance phenotypes were used. The first two Ae. aegypti lines, (IR13 and IR03 lines) were obtained from gravid females collected in the Ile Royale, an island off the coast of Cayenne, by the Pasteur Institute of French Guiana [29]. According to WHO manual for monitoring insecticide resistance, the IR13 line presented a slight tolerance to deltamethrin (mortality to discriminating concentration of deltamethrin ≥ 90%, but lower than 98%) and was considered as susceptible, whereas the IR03 line was considered as resistant to deltamethrin (mortality <90% to the discriminating concentration of deltamethrin) [30]. Previous study supported the absence of the V410L, S989P and V1016I/G kdr mutations in both IR03 and IR13 lines. However, both IR13 and IR03 lines initially carried the F1534C mutation at moderate frequency [29]. Another resistant line deprived from the F1534C kdr mutation (IRF) was created by internal crossing of the IR03 line. Despite the absence of the F1534C mutation, the IRF line remained resistant to deltamethrin [31], supporting the importance of metabolic resistance alleles in both resistant lines as previously shown [12,29,32,33]. All mosquito lines were reared using standard methods [27]. For eggs production, blood-meals were given through a Parafilm-membrane (hemotek membrane feeding systems, Discovery Workshops, UK) as previously described [24]. Larvae were reared until the pupal stage in trays containing 1liter distilled water supplemented with fish food (TetraMinBaby, Tetra Gmbh, Herrenteich, Germany). Pupae were daily collected and transferred to mosquito cages (Bug Dorm 1, Bioquip products). For mass spectrometry (MS) analysis, pupae female, distinguished by sexual dimorphism, were transferred to mosquito cages. Twenty virgin, non-blood fed, 3 days-old females per line were collected and frozen at -20°C until MS analysis.

Mosquito dissection

Legs and thoraxes of each mosquito were processed as previously described [34]. Briefly, Aedes specimens were individually dissected, under a binocular loupe, with a sterile surgical blade. For each specimen, legs and thorax (without wings) were transferred in distinct 1.5 mL Eppendorf tubes for MALDI-TOF MS analysis. The remaining body parts (abdomens, wings and heads) were preserved for molecular analyses.

Knockdown resistance (kdr) genotyping

Genomic DNA was extracted individually from the remaining body parts (abdomen, wings and head) of 20 individual adult specimens per line using the QIAamp DNA tissue extraction kit (Qiagen, Hilden, Germany), according to the manufacturer’s instructions. The kdr genotyping of V410L (a substitution of a valine to leucine at position 410), V1016I/G (i.e. a substitution of a valine to either isoleucine or glycine at position 1016) and F1534C (i.e. a substitution of a phenylalanine to cysteine at position 1534) were conducted by standard PCR (S1 Table) followed by sequencing as previously described [35].

Sample homogenization and MALDI-TOF MS analysis

Each body part (legs and thorax) was homogenized individually for 3 x 1 minute at 30 Hertz using TissueLyser (Qiagen) and glass beads (#11079110, BioSpec Products, Bartlesville, OK, US) in a homogenization buffer composed of a mix (50/50) of 70% (v/v) formic acid (Sigma) and 50% (v/v) acetonitrile (Fluka, Buchs, Switzerland) according to the standardized automated setting as described previously [27]. After sample homogenization, a quick spin centrifugation at 200 g for 1 min was then performed and 1 μL of the supernatant of each sample was spotted on the MALDI-TOF steel target plate in duplicate (Bruker Daltonics, Wissembourg, France). After air-drying, 1 μL of matrix solution composed of saturated α-cyano-4-hydroxycinnamic acid (Sigma, Lyon, France), 50% (v/v) acetonitrile, 2.5% (v/v) trifluoroacetic acid (Aldrich, Dorset, UK) and HPLC-grade water was added. To control matrix quality (i.e. absence of MS peaks due to matrix buffer impurities) and MALDI-TOF apparatus performance, matrix solution was loaded in duplicate onto each MALDI-TOF plate alone. Protein mass profiles were obtained using a Microflex LT MALDI-TOF Mass Spectrometer (Bruker Daltonics, Germany), with detection in the linear positive-ion mode at a laser frequency of 50 Hz within a mass range of 2–20 kDa. The setting parameters of the MALDI-TOF MS apparatus were identical to those previously used [36]. Daily, an automatic calibration of MALDI-TOF apparatus was done using a Bruker Bacterial Test Standard (BTS, ref: #8255343). In addition, to control quality of mosquito homogenization step and MALDI-TOF apparatus performance of each plate, highly relevant and correct identification score (LSVs >2.0) should be obtained for at least more than half of the legs or thoraxes from Ae. aegypti BORA specimens queried against the reference MS database. These identification parameters were used as internal QC to validate each plate.

MS spectra analysis

MS spectra profiles were firstly controlled visually with flexAnalysis v3.3 software (Bruker Daltonics). MS spectra were then exported to ClinProTools v2.2 and MALDI-Biotyper v3.0. (Bruker Daltonics) for data processing (smoothing, baseline subtraction, peak picking). MS spectra reproducibility was assessed by the comparison of the average spectral profiles (MSP, Main Spectrum Profile) obtained from the two spots of each specimen from legs and thorax according to Aedes lines with MALDI-Biotyper v3.0 software (Bruker Daltonics). MS spectra reproducibility and specificity were achieved using cluster analyses and Composite Correlation Index (CCI) tool. Cluster analyses (MSP dendrogram) were performed based on comparison of the MSP given by MALDI-Biotyper v3.0. software and clustered according to protein mass profile (i.e. their mass signals and intensities). The CCI tool from MALDI-Biotyper v3.0. software was also used, to assess the spectral variations within and between each sample group, as previously described [20,27]. CCI matrix was calculated using MALDI-Biotyper v3.0. software with default settings (mass range 3.0–12.0 kDa; resolution 4; 8 intervals; auto-correction off). Higher correlation values (expressed by mean ± standard deviation – SD) reflecting higher reproducibility for the MS spectra, were used to estimate MS spectra distance between lines. To visualize MS spectra distribution according to insecticide susceptibility, a principal component analysis (PCA) from ClinProTools v2.2 software was used with the default settings.

The spectra were then analysed with the genetic algorithm (GA) model, which displayed a list of discriminating peaks between the two insecticide susceptible lines (BORA and IR13) and the two resistant lines (IR03 and IFR). A manual inspection and validation of the selected peaks by the operator gave a recognition capability (RC) value together with the highest cross-validation (CV) value. The presence or absence of all discriminating peak masses generated by the GA model was controlled by comparing the average spectra from line per body-part.

Database creation and blind tests

The reference MS spectra were created using spectra from two specimens per line and per body parts (legs and thorax) using MALDI-Biotyper software v3.0. (Bruker Daltonics). MS spectra were created with an unbiased algorithm using information on the peak position, intensity and frequency. The remaining MS spectra per line and body part were queried against these reference MS spectra and a classification as deltamethrin-resistant or–susceptible was done according to the result of spectral matching with DB. The reliability of sample classification was determined using the Log Score Values (LSVs) given by the MALDI-Biotyper software v.3.0, corresponding to a matched degree of mass spectra between the query and the reference spectra from the DB. LSVs ranging from 0 to 3 were obtained for each spectrum of the samples tested. According to previous studies [28,37], LSVs greater than 1.8 were considered reliable for species identification. For evaluating it performance, the sensitivity, the specificity, the accuracy and the Cohen’s κ coefficient, corresponding to the degree of agreement [38], were calculated.

Statistical analyses

After verifying that the LSVs in each line did not follow a Gaussian distribution (Shapiro-Wilk test), Wilcoxon matched-pairs signed-rank tests were computed when appropriate using GraphPad Prism v7.00 (GraphPad Software, La Jolla California USA,). Frequencies were compared by the Chi-square test. All differences were considered significant at p < 0.05. For detection of discriminant MS peaks, statistical tests from ClinProTools v2.2 software, including t-test (ANOVA), the Wilcoxon or Kruskal-Wallis (W/KW) test and the Anderson-Darling (AD) test were applied, to short peaks among profiles. To consider a peak as discriminant, it should obtain a significant p-value (<0.05) in the AD test but also in the W/KW or ANOVA tests [39]. Among these discriminant MS peaks were selected those which presented a fold change upper than 1.3-fold between susceptible and resistant lines [40].

Ethical approval

The present work included only four colonies of Aedes aegypti mosquitoes, which were obtained from laboratory rearing. These mosquito species were not classified as endangered or protected species.

Results

Low MS spectra diversity between Ae. aegypti lines

Legs and thoraxes from 20 specimens per line (BORA, IR13, IR03 and IRF) were submitted independently to MALDI-TOF MS analysis (Fig 1). At the exception of the legs from one specimen from the IR03 line, MS profiles of high intensity (>2000 a.u.) were obtained for all samples from both body parts. To control MS spectra “quality”, they were queried against our MS spectra database (DB) which includes reference MS spectra of legs and thoraxes from 16 distinct mosquito species [27,28] and notably Ae. aegypti. One hundred percent of the legs and thoraxes MS spectra matched with reference MS spectra from Ae. aegypti with respective body parts. Respectively, 97.5% (78/80) and 100% (80/80) of the MS spectra from legs and thoraxes reached the threshold LSV of 1.8 considered as a successful identification (Fig 2A and 2B) [21,25]. It is interesting to note that LSVs from thoraxes were significantly higher than those obtained for legs (Wilcoxon test, p<0.0001). More than 98% (79/80) of the thoraxes presented a LSV upper than 2.0 whereas only 71.25% (57/80) of the MS spectra from legs reached this last threshold.

Fig 1.

Fig 1

Comparison of MALDI-TOF MS spectra from legs (A) and thoraxes (B) of four Aedes aegypti lines. Representative MS spectra of two Ae. aegypti specimens per line, susceptible (BORA (a, b) and IR13 (c, d)) or resistant (IR03 (e, f) and IRF (g, h)) to deltamethrin. a.u., arbitrary units; m/z, mass-to-charge ratio.

Fig 2. Reproducibility and specificity of MALDI-TOF MS spectra from Aedes aegypti lines according to body part.

Fig 2

LSVs obtained following homemade MS reference database query with MS spectra of the four Ae. aegypti lines from legs (A) and thoraxes (B). Twenty specimens per line were tested. Horizontal dashed lines represent the threshold value for reliable identification (LSV>1.8). LSVs, log score values; a.u., arbitrary units. (C) The same 20 MS spectra per line and body part were analysed using the composite correlation index (CCI) tool. Levels of MS spectra reproducibility are indicated in red and blue revealing relatedness and incongruence between spectra, respectively. The values correspond to the mean coefficient correlation and respective standard deviations obtained for paired condition comparisons. CCI were expressed as mean ± standard deviation. (D) MSP dendrogram of MALDI-TOF MS spectra from legs (red) and thoraxes (blue) of the four Ae. aegypti lines. Two specimens per lines and per body part are presented. The distance units correspond to the relative similarity of MS spectra. The dendrogram was created by Biotyper v3.0 software. Principal Component Analysis (PCA) dimensional image from thoraxes (E, n = 20) and legs (F, n = 20) MS spectra of the four lines. Red, green, blue and yellow dots correspond to BORA, IR13, IR03 and IRF Ae. aegypti lines, respectively.

To assess MS spectra reproducibility according to each Ae. aegypti line, CCI matrix, MSP dendrogram and PCA were performed. The low CCI obtained for the comparisons of paired MS spectra between thoraxes and legs (mean ± SD: 0.31 ± 0.11) sustained the specificity of each body-part protein profiles. As expected, higher CCI were obtained for specimens from the same line than between lines for each body part, excepted for IR03 legs (mean CCI±SD = 0.61±0.20, Fig 2C). This lower CCI value was attributed to the lower quality of MS spectra from one sample of the IR03 line. Moreover, values from thorax CCIs were more elevated than those of legs supporting that MS profiles from thoraxes were more reproducible. Interestingly, higher thorax CCIs were obtained between the two resistant lines (IR03 and IRF) and the IR13 susceptible line (mean ± SD: 0.93 ± 0.10), compared to the laboratory susceptible line (BORA) (mean ± SD: 0.77 ± 0.13). Similarly, the reproducibility of leg MS profiles was higher between lines originating from French Guiana.

To assess the reproducibility and specificity of the MS spectra from legs and thoraxes according to their deltamethrin resistance phenotype, a cluster analysis was performed. Two specimens per line were used for building a MSP dendrogram (Fig 2D). Legs and thoraxes clustered in distinct branches confirming the specificity of the MS spectra per body part. However, no gathering of the spectra was noticed according to the resistance status or line, excepted for BORA using the thoraxes. The PCAs performed per body part with spectra from all samples showed two clusters. One cluster encompassed the three lines from French Guiana (IR03, IR13 and IRF) and another one included the BORA line for spectra from thoraxes (Fig 2E) and legs (Fig 2F). These results highlighted that overall comparisons of MS profiles did not allow to clearly distinguish specimens according to their deltamethrin resistance status whatever the body-part tested.

Identification of discriminant MS peaks between deltamethrin-resistant and -susceptible lines

To assess whether it was possible to identify discriminating MS peaks according to the deltamethrin resistance status, the MS spectra from the 20 specimens per line were analyzed for each body part (leg and thorax), using ClinProTools software. Then, the average spectrum from the insecticide-resistant lines (IR03 and IRF) were compared to the susceptible lines (BORA and IR13). A total of 99 and 118 peaks were detected in the average spectra of legs and thoraxes, respectively. MS peaks were considered as discriminant if they have a fold change upper than 1.3-fold in either direction between the two groups and if these variations were considered as statistically significant according to criteria defined previously (see material and methods). After verification of the peak report, 10 and 11 MS peaks from legs and thoraxes respectively (Tables 1 and 2) were considered of significant different intensity between the two groups. To assess whether these MS peaks could be discriminatory among these groups, they were included in the genetic algorithm (GA) model from ClinProTools 2.2 software. The combination of the presence/absence of these MS peaks from each body part lead to high RC and CV values for legs (90.0% and 98.1% respectively) and also for thoraxes (92.5% and 97.5%, respectively).

Table 1. List of the discriminant MS peaks from legs between deltamethrin-resistant (IR03 and IRF) and–susceptible (BORA and IR13) Ae. aegypti lines.

Peak number Mass (Da) PTTA PW/KW PAD Average peak intensity
(mean ± SD in a.u.)
Fold change
R S Ratio R/S
16 4871.1# < 0.000001 0 < 0.000001 11.1 ± 7 3.59 ± 1.94 3.09
22 5387.5 0.00517 0.0132 < 0.000001 6.2 ± 3.24 4.76 ± 2.2 1.30
41 7019.9 < 0.000001 < 0.000001 < 0.000001 2.97 ± 1.05 1.94 ± 0.57 1.53
59 9072. 5 0.000364 0.000132 < 0.000001 5.51 ± 2.28 4.09 ± 2.1 1.35
64 9965.0 0.0000328 0.0000129 6.36E-06 3.09 ± 0.98 2.37 ± 0.89 1.30
70 10776.2 0.000345 0.00129 < 0.000001 6.32 ± 4.17 3.99 ± 2.82 1.58
83 12242.5 < 0.000001 < 0.000001 0.000151 2.11 ± 0.58 1.53 ± 0.36 1.38
93 14036.2 < 0.000001 0 < 0.000001 1.42 ± 0.36 0.97 ± 0.18 1.46
96 14851.6 0.0000565 0.0000882 < 0.000001 2.54 ± 1.17 1.78 ± 0.86 1.43
99 18145.0 5.79E-06 1.08E-06 < 0.000001 1.27 ± 0.44 0.94 ± 0.34 1.35

#MS peaks for which mass-to-charge ratio (m/z) were similar with thoraxes MS peak list (see Table 2). Da, Dalton; PTTA, p-value obtained by t-test; PW/KW, p-value obtained by Wilcoxon/Kruskal-Wallis test; PAD, p-value obtained by Anderson-Darling test; a.u., arbitrary unit; R, deltamethrin-resistant lines; S, deltamethrin-susceptible lines.

Table 2. List of the discriminant MS peaks from thoraxes between deltamethrin-resistant (IR03 and IRF) and–susceptible (BORA and IR13) Ae. aegypti lines.

Peak number Mass (Da) PTTA PW/KW PAD Average peak intensity
(mean ± SD in a.u.)
Fold change
R S Ratio R/S
5 3026.9 0.000465 0.00208 < 0.000001 1.96 ± 0.99 1.47 ± 0.49 1.33
16 4075.2 0.125 0.0112 < 0.000001 6.73 ± 8.2 5.02 ± 2.38 1.34
19 4432.1 0.0415 0.0175 < 0.000001 2.84 ± 2.03 2.15 ± 1.69 1.32
20 4446.3 0.0265 0.00243 < 0.000001 3.01 ± 2.11 2.18 ± 2.03 1.38
24 4569.6 0.000179 0.0000745 < 0.000001 4.37 ± 1.93 3.22 ± 1.5 1.36
29 4869.5# < 0.000001 0 < 0.000001 6.19 ± 4.22 2.19 ± 0.89 2.83
74 9066.7 < 0.000001 < 0.000001 < 0.000001 1.7 ± 0.32 4.18 ± 2.92 0.41
75 9095.5 < 0.000001 < 0.000001 < 0.000001 3.81 ± 1.74 2.28 ± 0.86 1.67
76 9140.8 9.98E-06 < 0.000001 < 0.000001 5.86 ± 3.84 3.38 ± 2.0 1.73
110 13267.5 2.19E-06 5.25E-06 < 0.000001 1.13 ± 0.32 1.56 ± 0.62 0.72
114 14030.0 < 0.000001 < 0.000001 0.000017 0.89 ± 0.21 0.66 ± 0.11 1.35

#MS peaks for which mass-to-charge ratio (m/z) were similar with legs MS peak list (see Table 1). Da. Dalton; PTTA, p-value obtained by t-test; PW/KW, p-value obtained by Wilcoxon/Kruskal-Wallis test; PAD, p-value obtained by Anderson-Darling test; a.u., arbitrary unit; R, deltamethrin-resistant lines; S, deltamethrin-susceptible lines.

Interestingly, one potential discriminant MS peak was shared between the two body parts with a m/z of about 4870 Da, corresponding to peak #16 in legs (Fig 3A–3C) and peak #29 in thorax (Fig 3D–3F). As the start and end masses of the peak #16 (4871.1) and #29 (4869.5) were at m/z from 4859.2 to 4883.3 and from 4855.7 to 4883.0, respectively, it was considered that these two peaks are the same. The m/z of this discriminant peak found in both body parts was set at about 4870 Da. This 4870 Da peak was of greater intensity in the deltamethrin resistant lines than in the two susceptible lines for both body parts (Tables 1 and 2). Interestingly, this peak was among the MS peak presenting the higher fold change (>2.8 fold) between resistant and susceptible-lines for both body parts (Tables 1 and 2). Moreover, with a respective average peak intensity of 11.1 arbitrary units (a.u.) and 6.7 a.u. for the leg and thorax peaks at about m/z 4870, these peaks were classified in the top ten and top thirty for leg and thorax profiles from deltamethrin-resistant lines (IR03 ad IRF). Submitting this single peak to the GA model lead to RC and CV values of 78.2% and 85.5%, respectively for legs and 79.8% and 85.6%, respectively for thoraxes. The detection of this peak in the IR13 susceptible line though at a lower intensity confirmed that no single peak was found exclusive of resistant-group species but that the discrimination was more attributed to intensity variations.

Fig 3. Variation of the MS peak at about 4870 m/z among the four Ae. aegypti lines according to their susceptibility to deltamethrin.

Fig 3

Overlay mean profile view of leg (A) and thorax (D) body parts according to Ae. aegypti lines. Line color code of each mosquito line is indicated in the top right part. Gel view of leg (B) and thorax (E) MS spectra from the 20 specimens per line. The two replicates loaded on the MS plate for each specimen per body part are presented. Spectra number (Sp.#) is indicated at left and peak intensity is illustrated by a grey scale in arbitrary units. The discriminant MS peak (m/z: 4870 Da) is indicated by an asterisk (*). Graphical representation of the intensity of the 4870 m/z MS peak from legs (C) and thoraxes (F) according to Ae. aegypti lines. Standard deviations of intensities are represented by vertical lines. A.U.: Arbitrary units; m/z: Mass to charge ratio; R: Lines classified deltamethrin-resistant; S: Lines classified deltamethrin-susceptible. The same color code was used for all the panels.

Assessment of blind test strategy to discriminate deltamethrin-resistant from -susceptible lines

MS spectra from two specimens per line and per body part were selected for creation of reference MS spectra (Additional file 1). These MS spectra were selected in order that those from the deltamethrin-resistant lines (IR03 and IRF) possessed the most discriminant peak detected in both body parts at about 4870 m/z, whereas, this MS peak was absent from the two susceptible lines (BORA, IR13). The remaining MS spectra from legs (n = 144, 18 samples per lines (x4) loaded in duplicate (x2)) and from thoraxes (n = 144) were queried against these reference MS spectra. Overall, 98.9% (n = 285/288) of the MS spectra queried against the database, obtained LSVs over 2.0, and all (100%) reached the threshold established for relevant identification (LSVs>1.8) (S1 Fig). The assessment of concordance of classification results (resistant or susceptible) between blind tests and lines revealed an agreement of 77.1% with a Cohen’s κ coefficient of 0.542 corresponding to a moderate agreement of the data for legs. Similarly, a moderate agreement (76.4% with a Cohen’s κ coefficient of 0.528) was obtained for thoraxes. The sensitivity and specificity of blind test strategy were, respectively, 72.2% and 81.9% for legs and 72.2% and 80.6% for thoraxes using the four Ae. aegypti lines as reference (Table 3).

Table 3. Comparison of the classification of Ae. aegypti lines according to deltamethrin-susceptibility.

Legs Thoraxes
Lines Lines
Resistant
(IR03, IRF)
Susceptible
(BORA, IR13)
Resistant
(IR03, IRF)
Susceptible
(BORA, IR13)
Blind tests* R 59 20 58 20
S 13 52 14 52
Total 72 72 72 72
Agreement (%) 77.1% 76.4%
Cohen’s κ # 0.542 (Moderate agreement) 0.528 (Moderate agreement)
Sensitivity (%) 72.2% 72.2%
Specificity (%) 81.9% 80.6%

*Results of spectra classification queried against the reference MS spectra included in the DB

#Coefficient of agreement, the agreement level is indicated into brackets, as previously defined [38]. DB, database; MS, mass spectrometry; Resistant, deltamethrin-resistant lines; Susceptible, deltamethrin-susceptible lines.

Potential association between the 4870 m/z MS peak and kdr mutations

For each specimen tested in the present study, the V410L, V1016G/I, and F1534C kdr mutations were genotyped in an attempt to identify their potential association with the 4870 m/z MS resistance discriminating peak. These SNPs were selected because they are known to be strongly associated to pyrethroid resistance in Ae. aegypti [4143]. Among the 20 specimens tested for each line, genotyping failed for 5 individuals (i.e. one IR13, one IRF and three IR03). All genotyped specimens from BORA, IR13 and IRF lines were free of kdr mutations in all three sites of VGSC gene (i.e., genotype frequency of 100% for VV/VV/FF haplotype), while 65% of IR03 lines were heterozygotes (haplotype VV/VV/FC) and 6% were homozygote resistant (haplotype VV/VV/CC) for the F1534C mutation (Table 4).

Table 4. Genotyping of V410L, V1016I and F1534C kdr mutations in the four lines of Aedes aegypti.

Genotypes (410/1016/1534)
Ae. aegypti lines VV/VV/FF VV/VV/FC VV/VV/CC Others combinations
BORA 20 0 0 0
IR13 19 0 0 0
IR03 5 11 1 0
IRF 19 0 0 0
Total 63 11 1 0

As the four lines were confirmed to be susceptible for the V410L and V1016G/I mutations, the potential association between the F1534C mutation and the 4870 m/z MS peak was investigated. The classification of the leg and thorax spectra according to genotypes (FF, FC or CC) did not show any association between F1534C genotypes and the abundance of 4870 m/z MS peak (S2 Fig). Indeed, the 4870 m/z MS peak was detected in half of the individuals carrying the mutation, either in heterozygosis or homozygosis mutant (FC or CC), and in all susceptible genotypes (FF) for both body parts. Altogether, this indicates that the 4870 m/z MS discriminant MS peak is not related to the V410L, V1016G/I, and F1534C kdr mutations.

Discussion

The success of MALDI-TOF MS profiling for mosquito species identification [44,45], detection of parasitic agents [34,46] and/or for the determination of blood feeding origin of engorged specimens [23,47] led us to investigate the potential of this tool for the detection of insecticide resistance. Here we focused on deltamethrin, the most widely used pyrethroid insecticide for the control of the main arboviral vector, Ae. aegypti. To reduce the impact of the genetic and environmental conditions on the outcomes, we selected three mosquito lines collected in the same region (French Guiana) and having close genetic backgrounds, including one line being susceptible to deltamethrin (IR13) and two confirmed deltamethrin-resistant lines (IR03 and IRF) [29]. In addition, the susceptible laboratory line Bora-Bora (BORA) carrying no resistance allele was tested to generate reference MS profile.

Prior to research MS peak markers associated to insecticide resistance, a quality control of the MS spectra was carried out by evaluating the accuracy of sample identification against a home-made reference spectrum DB. For the first query, no MS spectra from the three French Guiana Ae. aegypti lines were included in the spectra DB as reference. Nevertheless, a correct and relevant identification (LSV ≥1.8) was obtained for 98.8% (158/160) of the samples. The matching of these query leg and thorax MS spectra with those of Ae. aegypti from the DB coming from the laboratory (i.e., BORA) or the field [45] underlined that the spectra were conserved among these Ae. aegypti specimens from distinct origins (reproducibility of spectra). The presence of reference spectra from specimens of the same species was then sufficient for correct and reliable identification of species identification, confirming the compliance of the MS spectra dataset from legs and thoraxes for next analyses [24,27].

The significant higher LSVs obtained for thoraxes compared to legs confirmed the better MS spectra reproducibility of the thoraxes for species identification, as recently demonstrated [26]. Nevertheless, for both body parts, comparisons of CCI, cluster analysis and PCAs indicated that MS spectra were more reproducible among strains coming from the same geographical origin (the three lines from French Guiana) than from BORA line, which is originating from French Polynesia and has been maintained in the laboratory for more than 30 years. Indeed, the MS spectra from the BORA line slightly differed from those of French Guiana (IR03, IR13 and IRF) for both body parts, legs and thoraxes. These data also suggest that MS profiles from isofemale lines are closer among them than between specimens presenting the same properties regarding the deltamethrin susceptibility phenotype. These results are concordant with previous works which already reported that MS spectra from specimens of the same species were more homogeneous if they have the same geographical origin [21,26]. Then, the higher MS spectra homology according to specimen geographical origin underlined that the classification of specimens according to their deltamethrin susceptibility could not be elucidated by the analysis of the whole MS spectra, as it is commonly done for arthropod species classification by MALDI-TOF MS biotyping [48]. Then, we focused our work by looking at specific MS peaks that could distinguish specimens according to their deltamethrin susceptibility.

The comparison of the average spectrum intensity between the IR03 and IRF deltamethrin-resistant and the BORA and IR13 susceptible lines revealed multiple MS peaks with significant abundance variations for legs and thoraxes. These peaks allowed to classify correctly more than 90.0% of the specimens after applying a GA model on both body parts. These data underlined that less than a dozen of MS peaks per body part appeared sufficient to segregate both groups. Such imperfect classification is probably explained by the inter-individual variability exists in the lines tested and by other resistant markers (e.g. metabolic) which may be present in the mosquitoes originated from French Guiana lines [29].

In this kind of study, the difficulty is coming from the heterogeneity or spectra variation which occurred among specimens from the same species but coming from distinct origins. That’s why the main factors that can create spectra noise were controlled by using Ae. aegypti lines having the same genetic background (i.e. isofemales lines) and coming from the same geographical region. Moreover, the laboratory rearing of the four mosquito lines in standardized breeding conditions participated also to reduce spectra variation due to environmental factors. A recent study demonstrated that the application of machine learning models to MS spectra from legs or thoraxes from anopheline mosquitoes could detected biomarkers associated to diverse life history traits such as, the population age, past blood feeding or plasmodium infectious status [49].

Among the discriminant MS peaks, one peak, at about 4870 m/z, was found significantly more intense (fold change upper than 2.8) in deltamethrin-resistant lines as compared to the susceptible one’s. This peak was found in both legs and thoraxes. The application of GA model to this peak allowed to classify mosquito specimens as deltamethrin-susceptible or deltamethrin-resistant with a concordance of about 80%. Although promising, we have no guarantee that this peak is systematically and functionally associated to deltamethrin resistance. First of all, no association was found between kdr alleles at position 1534 (at heterozygote or homozygote haplotypes) and the abundance of 4870 m/z MS peak. No mutant kdr alleles were find at 1016 and 410 sites in all isofemale lines from French Guiana as initially reported [29], then no genotype-phenotype association studies were performed. Our data suggest that the deltamethrin resistance phenotype of the IR03 and IRF lines is not majorly caused by kdr mutations but most probably by other metabolic resistance alleles as previously reported [32]. In this regard, it is possible that the abundance of the 4870 m/z MS peak in deltamethrin-resistant lines rather reflects a change in the expression of particular detoxifying enzymes involved in deltamethrin-resistance, such as P450s. This peptide could also result from an indirect effect and could have a priori no causal link with the insecticide resistance phenotype. Clearly, further work is needed to assess the protein nature and function associated with this 4870 m/z MS peak. One way to do this may involve further association studies using the IRF line deprived from kdr mutations together with cross-comparison of MS data with molecular data obtained from loci associated with resistance. The tracking of this particular MS peak in a larger collection of resistant and susceptible populations may also help us to validate this association of this MS peak with resistance.

Finally, the functional characterization of the 4870 m/z MS peak is a priority. Although the identification of the other discriminant peaks could be helpful to establish their involvement in phenotypic deltamethrin-resistant trait, their lower peak intensity could compromise these characterizations. Conversely, the peak at m/z 4870 was among the top one for legs and top two for thoraxes of discriminant average peak intensity. Moreover, taking into account the whole spectra, this peak was among the more abundant. The identification of the protein/peptide will however require additional MS apparatus [50]. For example, the protein/peptide could identify by peptide-sequencing using tandem mass-spectrometry approach [51] and validated by immune detection (eg, ELISA, WB, etc) [52]. Regardless the technique, the identification and incrimination of this peak in deltamethrin-resistance could open the door for the development of novel diagnostic assays to track pyrethoid resistance.

Conclusions

The MALDI-TOF MS profiling is an innovative approach which proved to be a rapid, affordable and efficient method for the identification of vector species, blood feeding source and some pathogen infection. This emerging entomological strategy may also be relevant for identifying others mosquito life traits of major importance, such as insecticide resistance. Although, the analysis of global MS profiles failed to distinct susceptible to resistant phenotypes in the inbreed females, an accurate comparison of spectra allowed to reveal potential peaks associated to deltamethrin-resistance. This pioneering study requires further complementary experimental works and collaborative research efforts, to consider the potential outputs for the mosquito surveillance. The characterization of key mosquito life traits with a unique approach will be revolutionary for vector biology and the prevention of mosquito-borne diseases outbreaks.

Supporting information

S1 Fig

LSVs following upgrading homemade reference database with MS spectra from legs (A) and thoraxes (B) of the four Ae. aegypti lines. Eighteen specimens per line were tested. Horizontal dashed lines represent the threshold value for reliable identification (LSV>1.8). Red, green, blue and yellow dots correspond to BORA, IR13, IR03 and IRF Ae. aegypti lines, respectively. LSVs, log score values; a.u., arbitrary units.

(PPTX)

pone.0303027.s001.pptx (365.4KB, pptx)
S2 Fig. Variation of the MS peak at about 4870 m/z among the IR03 Ae. aegypti line according to their 1534 kdr genotyping.

Overlay mean profile view of leg (A) and thorax (D) body parts according to 1534 genotype. Line color code of each genotype is indicated in the top right part. Gel view of leg (B) and thorax (E) MS spectra from the IR03 specimens per genotype. The two replicates loaded on the MS plate for each specimen per body part are presented. The discriminant MS peak (m/z: 4870 Da) is indicated by an asterisk (*). Graphical representation of the intensity of the 4870 m/z MS peak from legs (C) and thoraxes (F) according to 1534 genotype of IR03 Ae. aegypti line. Standard deviations of intensities are represented by vertical lines. A.U.: arbitrary units; m/z: mass to charge ratio; Red: haplotype homozygotes without mutation (VV/VV/FF); Green: mutant haplotype heterozygotes (VV/VV/FC) and homozygotes (VV/VV/CC). The same color code was used for all the panels.

(PPTX)

pone.0303027.s002.pptx (199.2KB, pptx)
S1 Table. Primer pairs used for detection of kdr mutation points.

(DOCX)

pone.0303027.s003.docx (13.3KB, docx)
S1 File. Raw leg and thorax MS spectra from the four Ae. aegypti lines included in the MS reference database.

MS spectra were obtained using Microflex LT MALDI-TOF Mass Spectrometer (Bruker Daltonics). Details of each sample were listed of the excel file named “REF_MS_Spectra_Mosq_Guiana_Body-parts_IRS_August-2023”.

(ZIP)

pone.0303027.s004.zip (2.2MB, zip)

Acknowledgments

We thank the “Fondation Méditerranée Infection (FMI)” and the WIN (Worldwide Insecticide resistance Network) for their administrative support.

Abbreviations

Ae

Aedes

CCI

Composite Correlation Index

CV

cross-validation

DDT

dichlorodiphenyltrichloroethane

GA

genetic algorithm

IR

insecticide resistance

kdr

knockdown resistance

LSV

Log Score Value

MALDI-TOF MS

Matrix Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry

MSP

Main Spectra Projection

PCA

principal component analysis

RC

recognition capability

RSDB

reference spectra database

VGSC

voltage-gated sodium channel

Data Availability

All relevant data are within the manuscript and its Supporting Information files.

Funding Statement

AL received the following award This work has been supported by the Délégation Générale pour l’Armement (DGA), MSProfileR project, Grant no PDH-2-NRBC-2-B-2201 This work was also supported by the WIN (Worldwide Insecticide resistance Network).

References

  • 1.Chala B, Hamde F. Emerging and Re-emerging Vector-Borne Infectious Diseases and the Challenges for Control: A Review. Front Public Health. 2021; 9:715759. doi: 10.3389/fpubh.2021.715759 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Fontaine A, Diouf I, Bakkali N, et al. Implication of haematophagous arthropod salivary proteins in host-vector interactions. Parasit Vectors. 2011; 4:187. doi: 10.1186/1756-3305-4-187 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Corbel V, Achee NL, Chandre F, et al. Tracking Insecticide Resistance in Mosquito Vectors of Arboviruses: The Worldwide Insecticide resistance Network (WIN). PLoS Negl Trop Dis. 2016; 10(12):e0005054. doi: 10.1371/journal.pntd.0005054 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Roiz D, Wilson AL, Scott TW, et al. Integrated Aedes management for the control of Aedes-borne diseases. PLoS Negl Trop Dis. 2018; 12(12):e0006845. doi: 10.1371/journal.pntd.0006845 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Moyes CL, Vontas J, Martins AJ, et al. Contemporary status of insecticide resistance in the major Aedes vectors of arboviruses infecting humans. PLoS Negl Trop Dis. 2017; 11(7):e0005625. doi: 10.1371/journal.pntd.0005625 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Kasai S, Caputo B, Tsunoda T, et al. First detection of a Vssc allele V1016G conferring a high level of insecticide resistance in Aedes albopictus collected from Europe (Italy) and Asia (Vietnam), 2016: a new emerging threat to controlling arboviral diseases. Euro Surveill Bull Eur Sur Mal Transm Eur Commun Dis Bull. 2019; 24(5). doi: 10.2807/1560-7917.ES.2019.24.5.1700847 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Fotakis EA, Chaskopoulou A, Grigoraki L, et al. Analysis of population structure and insecticide resistance in mosquitoes of the genus Culex, Anopheles and Aedes from different environments of Greece with a history of mosquito borne disease transmission. Acta Trop. 2017; 174:29–37. doi: 10.1016/j.actatropica.2017.06.005 [DOI] [PubMed] [Google Scholar]
  • 8.Auteri M, La Russa F, Blanda V, Torina A. Insecticide Resistance Associated with kdr Mutations in Aedes albopictus: An Update on Worldwide Evidences. BioMed Res Int. 2018; 2018:3098575. doi: 10.1155/2018/3098575 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Martinez-Torres D, Chandre F, Williamson MS, et al. Molecular characterization of pyrethroid knockdown resistance (kdr) in the major malaria vector Anopheles gambiae s.s. Insect Mol Biol. 1998; 7(2):179–184. doi: 10.1046/j.1365-2583.1998.72062.x [DOI] [PubMed] [Google Scholar]
  • 10.Brengues C, Hawkes NJ, Chandre F, et al. Pyrethroid and DDT cross-resistance in Aedes aegypti is correlated with novel mutations in the voltage-gated sodium channel gene. Med Vet Entomol. 2003; 17(1):87–94. doi: 10.1046/j.1365-2915.2003.00412.x [DOI] [PubMed] [Google Scholar]
  • 11.Silva JJ, Kouam CN, Scott JG. Levels of cross-resistance to pyrethroids conferred by the Vssc knockdown resistance allele 410L+1016I+1534C in Aedes aegypti. PLoS Negl Trop Dis. 2021; 15(7):e0009549. doi: 10.1371/journal.pntd.0009549 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Cattel J, Faucon F, Le Péron B, et al. Combining genetic crosses and pool targeted DNA-seq for untangling genomic variations associated with resistance to multiple insecticides in the mosquito Aedes aegypti. Evol Appl. 2020; 13(2):303–317. doi: 10.1111/eva.12867 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Cattel J, Haberkorn C, Laporte F, et al. A genomic amplification affecting a carboxylesterase gene cluster confers organophosphate resistance in the mosquito Aedes aegypti: From genomic characterization to high-throughput field detection. Evol Appl. 2021; 14(4):1009–1022. doi: 10.1111/eva.13177 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Balabanidou V, Grigoraki L, Vontas J. Insect cuticle: a critical determinant of insecticide resistance. Curr Opin Insect Sci. 2018; 27:68–74. doi: 10.1016/j.cois.2018.03.001 [DOI] [PubMed] [Google Scholar]
  • 15.Balabanidou V, Kefi M, Aivaliotis M, et al. Mosquitoes cloak their legs to resist insecticides. Proc Biol Sci. 2019; 286(1907):20191091. doi: 10.1098/rspb.2019.1091 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Dusfour I, Vontas J, David J-P, et al. Management of insecticide resistance in the major Aedes vectors of arboviruses: Advances and challenges. PLoS Negl Trop Dis. 2019; 13(10):e0007615. doi: 10.1371/journal.pntd.0007615 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Yssouf A, Almeras L, Raoult D, Parola P. Emerging tools for identification of arthropod vectors. Future Microbiol. 2016; 11(4):549–566. doi: 10.2217/fmb.16.5 [DOI] [PubMed] [Google Scholar]
  • 18.Sevestre J, Diarra AZ, Laroche M, Almeras L, Parola P. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry: an emerging tool for studying the vectors of human infectious diseases. Future Microbiol. 2021. doi: 10.2217/fmb-2020-0145 [DOI] [PubMed] [Google Scholar]
  • 19.Sambou M, Aubadie-Ladrix M, Fenollar F, et al. Comparison of matrix-assisted laser desorption ionization-time of flight mass spectrometry and molecular biology techniques for identification of Culicoides (Diptera: ceratopogonidae) biting midges in senegal. J Clin Microbiol. 2015; 53(2):410–418. doi: 10.1128/JCM.01855-14 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Diarra AZ, Almeras L, Laroche M, et al. Molecular and MALDI-TOF identification of ticks and tick-associated bacteria in Mali. PLoS Negl Trop Dis. 2017; 11(7):e0005762. doi: 10.1371/journal.pntd.0005762 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Yssouf A, Parola P, Lindström A, et al. Identification of European mosquito species by MALDI-TOF MS. Parasitol Res. 2014; 113(6):2375–2378. doi: 10.1007/s00436-014-3876-y [DOI] [PubMed] [Google Scholar]
  • 22.Yssouf A, Socolovschi C, Leulmi H, et al. Identification of flea species using MALDI-TOF/MS. Comp Immunol Microbiol Infect Dis. 2014; 37(3):153–157. doi: 10.1016/j.cimid.2014.05.002 [DOI] [PubMed] [Google Scholar]
  • 23.Niare S, Berenger J-M, Dieme C, et al. Identification of blood meal sources in the main African malaria mosquito vector by MALDI-TOF MS. Malar J. 2016; 15:87. doi: 10.1186/s12936-016-1152-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Dieme C, Yssouf A, Vega-Rúa A, et al. Accurate identification of Culicidae at aquatic developmental stages by MALDI-TOF MS profiling. Parasit Vectors. 2014; 7:544. doi: 10.1186/s13071-014-0544-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Nebbak A, Willcox AC, Bitam I, Raoult D, Parola P, Almeras L. Standardization of sample homogenization for mosquito identification using an innovative proteomic tool based on protein profiling. Proteomics. 2016; 16(24):3148–3160. doi: 10.1002/pmic.201600287 [DOI] [PubMed] [Google Scholar]
  • 26.Bamou R, Costa MM, Diarra AZ, Martins AJ, Parola P, Almeras L. Enhanced procedures for mosquito identification by MALDI-TOF MS. Parasit Vectors. 2022; 15(1):240. doi: 10.1186/s13071-022-05361-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Vega-Rúa A, Pagès N, Fontaine A, et al. Improvement of mosquito identification by MALDI-TOF MS biotyping using protein signatures from two body parts. Parasit Vectors. 2018; 11(1):574. doi: 10.1186/s13071-018-3157-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Briolant S, Costa MM, Nguyen C, et al. Identification of French Guiana anopheline mosquitoes by MALDI-TOF MS profiling using protein signatures from two body parts. PloS One. 2020; 15(8):e0234098. doi: 10.1371/journal.pone.0234098 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Epelboin Y, Wang L, Giai Gianetto Q, et al. CYP450 core involvement in multiple resistance strains of Aedes aegypti from French Guiana highlighted by proteomics, molecular and biochemical studies. PloS One. 2021; 16(1):e0243992. doi: 10.1371/journal.pone.0243992 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.World Health Organization. Manual for monitoring insecticide resistance in mosquito vectors and selecting appropriate interventions [Internet]. 2022. Available from: https://www.who.int/publications/i/item/9789240051089. [Google Scholar]
  • 31.Bacot T, Haberkorn C, Guilliet J, et al. A large genomic duplication spanning multiple P450s contributes to pyrethroid resistance in the dengue mosquito Aedes aegypti [Internet]. Petit Pois Déridé; 2022. Available from: https://ppd2022.sciencesconf.org/resource/page/id/1 [Google Scholar]
  • 32.Faucon F, Dusfour I, Gaude T, et al. Identifying genomic changes associated with insecticide resistance in the dengue mosquito Aedes aegypti by deep targeted sequencing. Genome Res. 2015; 25(9):1347–1359. doi: 10.1101/gr.189225.115 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Faucon F, Gaude T, Dusfour I, et al. In the hunt for genomic markers of metabolic resistance to pyrethroids in the mosquito Aedes aegypti: An integrated next-generation sequencing approach. PLoS Negl Trop Dis. 2017; 11(4):e0005526. doi: 10.1371/journal.pntd.0005526 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Tahir D, Almeras L, Varloud M, Raoult D, Davoust B, Parola P. Assessment of MALDI-TOF mass spectrometry for filariae detection in Aedes aegypti mosquitoes. PLoS Negl Trop Dis. 2017; 11(12):e0006093. doi: 10.1371/journal.pntd.0006093 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Murcia O, Henríquez B, Castro A, et al. Presence of the point mutations Val1016Gly in the voltage-gated sodium channel detected in a single mosquito from Panama. Parasit Vectors. 2019; 12(1):62. doi: 10.1186/s13071-019-3309-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Lafri I, Almeras L, Bitam I, et al. Identification of Algerian Field-Caught Phlebotomine Sand Fly Vectors by MALDI-TOF MS. PLoS Negl Trop Dis. 2016; 10(1):e0004351. doi: 10.1371/journal.pntd.0004351 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Costa MM, Guidez A, Briolant S, et al. Identification of Neotropical Culex Mosquitoes by MALDI-TOF MS Profiling. Trop Med Infect Dis. 2023; 8(3):168. doi: 10.3390/tropicalmed8030168 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977; 33(1):159–174. [PubMed] [Google Scholar]
  • 39.Rocca MF, Zintgraff JC, Dattero ME, et al. A combined approach of MALDI-TOF mass spectrometry and multivariate analysis as a potential tool for the detection of SARS-CoV-2 virus in nasopharyngeal swabs. J Virol Methods. 2020; 286:113991. doi: 10.1016/j.jviromet.2020.113991 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Fraisier C, Camoin L, Lim SM, et al. Altered protein networks and cellular pathways in severe west nile disease in mice. PloS One. 2013; 8(7):e68318. doi: 10.1371/journal.pone.0068318 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Hernandez JR, Liu S, Fredregill CL, Pietrantonio PV. Impact of the V410L kdr mutation and co-occurring genotypes at kdr sites 1016 and 1534 in the VGSC on the probability of survival of the mosquito Aedes aegypti (L.) to Permanone in Harris County, TX, USA. PLoS Negl Trop Dis. 2023; 17(1):e0011033. doi: 10.1371/journal.pntd.0011033 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Linss JGB, Brito LP, Garcia GA, et al. Distribution and dissemination of the Val1016Ile and Phe1534Cys Kdr mutations in Aedes aegypti Brazilian natural populations. Parasit Vectors. 2014; 7:25. doi: 10.1186/1756-3305-7-25 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Marcombe S, Mathieu RB, Pocquet N, et al. Insecticide resistance in the dengue vector Aedes aegypti from Martinique: distribution, mechanisms and relations with environmental factors. PloS One. 2012; 7(2):e30989. doi: 10.1371/journal.pone.0030989 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Müller P, Pflüger V, Wittwer M, et al. Identification of cryptic Anopheles mosquito species by molecular protein profiling. PloS One. 2013; 8(2):e57486. doi: 10.1371/journal.pone.0057486 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Yssouf A, Socolovschi C, Flaudrops C, et al. Matrix-assisted laser desorption ionization—time of flight mass spectrometry: an emerging tool for the rapid identification of mosquito vectors. PloS One. 2013; 8(8):e72380. doi: 10.1371/journal.pone.0072380 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Laroche M, Almeras L, Pecchi E, et al. MALDI-TOF MS as an innovative tool for detection of Plasmodium parasites in Anopheles mosquitoes. Malar J. 2017; 16(1):5. doi: 10.1186/s12936-016-1657-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Tandina F, Laroche M, Davoust B, K Doumbo O, Parola P. Blood meal identification in the cryptic species Anopheles gambiae and Anopheles coluzzii using MALDI-TOF MS. Parasite Paris Fr. 2018; 25:40. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Abdellahoum Z, Nebbak A, Lafri I, et al. Identification of Algerian field-caught mosquito vectors by MALDI-TOF MS. Vet Parasitol Reg Stud Rep. 2022; 31:100735. doi: 10.1016/j.vprsr.2022.100735 [DOI] [PubMed] [Google Scholar]
  • 49.Nabet C, Chaline A, Franetich J-F, et al. Prediction of malaria transmission drivers in Anopheles mosquitoes using artificial intelligence coupled to MALDI-TOF mass spectrometry. Sci Rep. 2020; 10(1):11379. doi: 10.1038/s41598-020-68272-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Guthals A, Bandeira N. Peptide identification by tandem mass spectrometry with alternate fragmentation modes. Mol Cell Proteomics MCP. 2012; 11(9):550–557. doi: 10.1074/mcp.R112.018556 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Zhang X, Scalf M, Berggren TW, Westphall MS, Smith LM. Identification of mammalian cell lines using MALDI-TOF and LC-ESI-MS/MS mass spectrometry. J Am Soc Mass Spectrom. 2006; 17(4):490–499. doi: 10.1016/j.jasms.2005.12.007 [DOI] [PubMed] [Google Scholar]
  • 52.Lefranc D, Dubucquoi S, Almeras L, et al. Molecular analysis of endogenous retrovirus HRES-1: identification of frameshift mutations in region encoding putative 28-kDa autoantigen. Biochem Biophys Res Commun. 2001; 283(2):437–444. doi: 10.1006/bbrc.2001.4814 [DOI] [PubMed] [Google Scholar]
PLoS One. 2024 May 10;19(5):e0303027. doi: 10.1371/journal.pone.0303027.r001

Author response to previous submission


Transfer Alert

This paper was transferred from another journal. As a result, its full editorial history (including decision letters, peer reviews and author responses) may not be present.

21 Feb 2024

Attachment

Submitted filename: Responses_to_reviewer_Comments_R1.docx

pone.0303027.s005.docx (31KB, docx)

Decision Letter 0

Joseph Banoub

22 Mar 2024

PONE-D-24-05959Potential of MALDI-TOF MS biotyping to detect deltamethrin resistance in the dengue vector Aedes aegypti.PLOS ONE

Dear Dr. ALMERAS,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by May 06 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Joseph Banoub, Ph,D., D. Sc.

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match. 

When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section.

3. Thank you for stating the following financial disclosure: 

"AL received the following award

This work has been supported by the Délégation Générale pour l’Armement (DGA), MSProfileR project, Grant no PDH-2-NRBC-2-B-2201

This work was also supported by the WIN (Worldwide Insecticide resistance Network)"

Please state what role the funders took in the study.  If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." If this statement is not correct you must amend it as needed. 

Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf.

4. Thank you for stating the following in the Acknowledgments Section of your manuscript: 

"We thank the “Fondation Méditerranée Infection (FMI)” which offered personnel grant to MMC and the WIN (Worldwide Insecticide resistance Network) which contributed in the travelling of the student between Brazil and France."

Please note that funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. 

Please remove any funding-related text from the manuscript.

5. We are unable to open your Supporting Information file [Additional_file_1_DB.7z]. Please kindly revise as necessary and re-upload.

Additional Editor Comments:

It will be appreciated to revise your manuscript according to all suggestion of the referees.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: I Don't Know

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The article "Potential of MALDI-TOF MS biotyping to detect deltamethrin resistance in the dengue vector Aedes aegypti" describes a new diagnostic approach based on protein profile signatures using MALDI-TOF-MS instrument and identification by an MS reference spectra database to determine pyrethroid insecticide resistance in mosquitoes. In this context, the study suggests performing a comparison of various MS profiles from four Ae. aegypti colonies, backed by statistical analysis tools. This audacious proposal seeks an alternative advanced diagnostic method using protein profiling data analysis by MALDI-TOF-MS to detect resistant mosquitoes at high-throughput levels.

The scientific work is really promising and crucial. Overall, the text is well written and abundant in experiment and outcome data. However, I believe the text is incomplete; certain decisive conclusions are not effectively interpreted and require more, pertinent interpretation. I agree to have this work published in the journal PLOS ONE only if the following adjustments are made and the issues are addressed.

� Introduction, pages 3 to 4:

Line 53: missing a reference

Line 59: “…in vector control for decades has selected mosquito…” do you mean developed

Line 96: replace deltamethrin with pyrethroid ester insecticide

� Sample homogenization and MALDI-TOF MS, pages 5-6 lines 137-150:

How did you perform the MALDI-TOF-MS calibration during the experiment? Please add the calibration method to the paper.

� Database creation and blind tests pages 6 to 7 lines 173-183:

-The quality of MALDI-TOF mass spectra may be affected by the following factors: technical knowledge of acquiring MALDI-TOF mass spectra, such as regular staff training and quality control of MALDI-TOF MS measurements, factors affecting spectrum acquisition settings, such as the number of laser shots applied and spectra averaged per measurement. Have you carried out routine diagnostics (QC tests) using standardized MALDI-TOF MS spectral quality?

-Did you prepare any pooled sample by homogenizing both parts legs and thorax? This pooled sample could be applied as a quality control for MS data correction and normalization.

� Results, pages 8-11 lines 195-296:

-Lines 222-224: “These results highlighted that overall comparisons of MS profiles did not allow to clearly distinguishing specimens according to their deltamethrin resistance status whatever the body- part tested.” I do not agree with the statement above. In my opinion, your spectra will at least show the peak height intensity difference if you normalize them.

-According to the PCA, there is a significant difference between BORA (French Polynesia) and the three others (French Guiana). I think you have multivariable factors to be taken into consideration.

-Have you tried multivariable study?

-Have you tried Partial Least-Squares Discriminant Analysis (PLS-DA)?

-Line 263: “m/z of about 4870 Da”, I see in Table 1 that peak #16 is at m/z 4871.1 (TOF analyzer associated in general with high-resolution MS)

-Please add peak annotation (at least peptide sequence)

-Lines 253-257, Table 2 peak #29, I see m/z 4869.5 and not m/z 4870.

In my opinion, peaks #16 and #29 observed in both leg and thorax might be different

-Page 11, lines 278-296 Potential association between the 4870 m/z MS peak and kdr mutations: Indeed, this is a very important study; did you consider associating other m/z significant MS peaks? Why only 4870 m/z? the other m/z values have a fold change of more than one.

-The discriminant MS peaks (observed in Tables 1&2 form legs and thorax deltamethrin-resistant (IR03 and IRF) and susceptible (BORA and IR13) Ae. aegypti line (BORA and IR13) Ae. aegypti lines) are all significant and they all present a potential biomarker for the resistant-group species. In this case, you should reconsider the data interpretation to value more these findings.

� Discussion

Line 361, the discussion should be extended to other m/z ions observed in table 1 and 2

� Conclusion: the conclusion is very general and brief

-Rewrite the conclusion to highlight the importance of MALDI-TOF-MS in monitoring deltamethrin resistance in the dengue vector Aedes aegypti. I agree that this pioneering effort requires further development in the future. However, you should put more value to the findings in this work especially related to the m/z list found in Tables 1 and 2, which in my opinion should be more discussed and analyzed pertinently. This work is missing a biological survey of the other peak discovered, which would provide us with a better understanding of the true biomarker associated with deltamethrin resistance.

� Figures

-Figure 1: The mass spectra have different intensity scales; please consider normalizing the MS by putting a common intensity scale for better comparison.

-Figure 2: PCA is not clear and the legend is very small, please reconsider the font size of the figure to be better readable.

-Figure 3 (A &D) is not clear, it is difficult to read the m/z for the peak you mentioned.

Reviewer #2: In this paper, the authors have utilised MALDI-TOF-MS protein/peptide fingerprinting in an attempt to find any discriminating peaks between different Ae. aegypti deltamethrin resistant and susceptible lines. The analysis was performed using two body parts, thorax and legs. The resulting spectra was compared and analysed using various statistical tools leading to the identification of a peak at m/z 4870 representing the higher fold change (>2.8 fold) between resistant and susceptible-lines for both body parts.

I have some points that need to be clarified regarding the MS data analysis and the two peaks at m/z 4871.1 and m/z 4869.5 detected from legs and thorax, respectively.

1- The difference between m/z 4871.1 and m/z 4869.5 is 1.6 Da. This indicates that these two peaks could be completely different as most peptide searches are usually done within +/-0.2 Da. So, what are the criteria used to decide if two peaks are similar or not?

Also, it is not clear in the manuscript what mass tolerance used for searching the spectra against the reference MS spectra from the 16 distinct mosquito species. Is this database available for everyone to use and approved for reliable species identification? Is it just a list of m/z values? Does it include Protein/Peptide IDs? Were the IDs supported by tandem mass spectrometry (MS/MS)?

2- These two peaks (m/z 4871.1 and m/z 4869.5) have extremely low signal intensities in the range of 2-11 a.u (Tables 1 and 2). So, what are the parameters used to evaluate the data and/or to filter real signals from noise? i.e. what is the minimum S/N ratio, signal intensity or relative intensity to create a peak list of 99 and 118 peaks detected in legs and thoraxes, respectively?

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2024 May 10;19(5):e0303027. doi: 10.1371/journal.pone.0303027.r003

Author response to Decision Letter 0


15 Apr 2024

To support our responses, new figures were added in the responses to reviewer comments, then the responses to reviewer comments and journal asks were included in a response letter loaded at the "attach files" step with the new version of the manuscript. The file name was headed “Responses_to_reviewer Comments_R1_PONE”.

Attachment

Submitted filename: Responses_to_reviewer Comments_R1_PONE.docx

pone.0303027.s006.docx (958.6KB, docx)

Decision Letter 1

Joseph Banoub

18 Apr 2024

Potential of MALDI-TOF MS biotyping to detect deltamethrin resistance in the dengue vector Aedes aegypti.

PONE-D-24-05959R1

Dear Dr. ALMERAS,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

I really would like to thank you for the excellent answers to the queries of the referees of this manuscript. It was quite informative and very well written.

Kind regards,

Joseph Banoub, Ph,D., D. Sc.

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

Joseph Banoub

29 Apr 2024

PONE-D-24-05959R1

PLOS ONE

Dear Dr. ALMERAS,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Joseph Banoub

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Fig

    LSVs following upgrading homemade reference database with MS spectra from legs (A) and thoraxes (B) of the four Ae. aegypti lines. Eighteen specimens per line were tested. Horizontal dashed lines represent the threshold value for reliable identification (LSV>1.8). Red, green, blue and yellow dots correspond to BORA, IR13, IR03 and IRF Ae. aegypti lines, respectively. LSVs, log score values; a.u., arbitrary units.

    (PPTX)

    pone.0303027.s001.pptx (365.4KB, pptx)
    S2 Fig. Variation of the MS peak at about 4870 m/z among the IR03 Ae. aegypti line according to their 1534 kdr genotyping.

    Overlay mean profile view of leg (A) and thorax (D) body parts according to 1534 genotype. Line color code of each genotype is indicated in the top right part. Gel view of leg (B) and thorax (E) MS spectra from the IR03 specimens per genotype. The two replicates loaded on the MS plate for each specimen per body part are presented. The discriminant MS peak (m/z: 4870 Da) is indicated by an asterisk (*). Graphical representation of the intensity of the 4870 m/z MS peak from legs (C) and thoraxes (F) according to 1534 genotype of IR03 Ae. aegypti line. Standard deviations of intensities are represented by vertical lines. A.U.: arbitrary units; m/z: mass to charge ratio; Red: haplotype homozygotes without mutation (VV/VV/FF); Green: mutant haplotype heterozygotes (VV/VV/FC) and homozygotes (VV/VV/CC). The same color code was used for all the panels.

    (PPTX)

    pone.0303027.s002.pptx (199.2KB, pptx)
    S1 Table. Primer pairs used for detection of kdr mutation points.

    (DOCX)

    pone.0303027.s003.docx (13.3KB, docx)
    S1 File. Raw leg and thorax MS spectra from the four Ae. aegypti lines included in the MS reference database.

    MS spectra were obtained using Microflex LT MALDI-TOF Mass Spectrometer (Bruker Daltonics). Details of each sample were listed of the excel file named “REF_MS_Spectra_Mosq_Guiana_Body-parts_IRS_August-2023”.

    (ZIP)

    pone.0303027.s004.zip (2.2MB, zip)
    Attachment

    Submitted filename: Responses_to_reviewer_Comments_R1.docx

    pone.0303027.s005.docx (31KB, docx)
    Attachment

    Submitted filename: Responses_to_reviewer Comments_R1_PONE.docx

    pone.0303027.s006.docx (958.6KB, docx)

    Data Availability Statement

    All relevant data are within the manuscript and its Supporting Information files.


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES